FDA approves Lonsurf/ bevacizumab combination for mCRC treatment
The approval is based on the results of the Phase 3 SUNLIGHT trial in which the combination of…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
03 Aug 23
The approval is based on the results of the Phase 3 SUNLIGHT trial in which the combination of…
03 Aug 23
In the lawsuit filed in federal court in Delaware, GSK alleged that Pfizer used many of its vaccine…
03 Aug 23
The company will continue to assess the entire dataset of the late-stage study to determine the drug candidate's…
03 Aug 23
The collaboration intends to leverage T-CAIREM's translational research in AI and FACIT's unique commercialisation-venture model to foster the…
03 Aug 23
Under the collaboration, all the products in the portfolio will continue to be marketed through affiliates in seven…
02 Aug 23
Anser TDM services, a range of homogenous mobility shift tests, are said to be useful for clinicians who…
02 Aug 23
The transaction is intended to add more than $1bn in net cash to Revolution Medicines’ balance sheet and…
02 Aug 23
Under the terms of the agreement, ProQR will get an initial payment of €12.5m and will also be…
01 Aug 23
Breyna is said to be the first generic version of AstraZeneca's Symbicort with US Food and Drug Administration…
01 Aug 23
The approval was backed by the results from the Phase 3 trial in which Ztalmy showed a median…